WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹-108 Cr | ₹-139 Cr | ₹-194 Cr | ₹-184 Cr | ₹-266 Cr |
What is the latest Profit & Loss Account Balance ratio of WANBURY ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2025 | ₹-108 Cr |
| Mar2024 | ₹-139 Cr |
| Mar2023 | ₹-194 Cr |
| Mar2022 | ₹-184 Cr |
| Mar2021 | ₹-266 Cr |
How is Profit & Loss Account Balance of WANBURY Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2025 | ₹-108 Cr | Negative | |
| Mar2024 | ₹-139 Cr | Negative | |
| Mar2023 | ₹-194 Cr | Negative | |
| Mar2022 | ₹-184 Cr | Negative | |
| Mar2021 | ₹-266 Cr | - | |
Compare Profit & Loss Account Balance of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹890.1 Cr | -1.2% | -2.1% | -2.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,075.0 Cr | 0.4% | 10.8% | 10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,486.0 Cr | 0.7% | 9.5% | 16.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,124.0 Cr | -2.5% | 6% | 36.2% | Stock Analytics | |
| CIPLA | ₹115,641.0 Cr | 9.7% | 16.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,589.0 Cr | 4.5% | 9.7% | 9% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | -1.2% |
-2.1% |
-2.2% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses